Clinical trial registry record

Evaluation of the Effect of a Seaweed Flour- and Leucine-Enriched Food on Metabolic and Inflammatory Status in Older Adults With Probable Sarcopenia or Sarcopenia

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Not Yet Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated July 8, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07689994
Last registry update
July 8, 2026
Status
Not Yet Recruiting
Phase
Phase not reported
Sponsor
Finis Terrae University
Enrollment
102
Countries
Chile
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · OTHER · TRIPLE
Evidence population
Human clinical study registration
Participants
102
Population
ALL · 60 Years
Duration
2026-08-01 to 2027-03-01
Intervention
Standard chocolate-flavored cake; Leucine-Enriched Chocolate Cake; Leucine Plus Seaweed Flour-Enriched Chocolate Cake
Comparator
Control chocolate cake; Leucine-enriched chocolate cake
Outcomes measured
Change from baseline in fasting serum transthyretin concentration at day 28. — 28 days; Change from baseline in handgrip strength at day 28. — 28 days; Change from baseline in 4-meter gait speed at day 28. — 28 days; Change from baseline in appendicular muscle mass index at day 28. — 28 days; Percentage (%) of prescribed study product serving consumed during the intervention. — 28 days; Number of participants with adequate adherence during the intervention. — 28 days
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Sarcopenia · 100%Title contains controlled term: sarcopenia. Abstract contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: older adult. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

sarcopenia
Open primary sourceExport JSON